NCT06304168View on ClinicalTrials.gov

Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

RecruitingOBSERVATIONAL
Enrollment

6,150

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

May 15, 2028

Study Completion Date

May 15, 2028

Conditions
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER